Medical Glycomics for Chronic Diseases
Metabolic/Endocrine Disorders, Inflammatory Conditions, Cardiovascular Diseases, Cancers, Degenerative Brain Diseases
ResearchActive
Key Facts
Indication
Metabolic/Endocrine Disorders, Inflammatory Conditions, Cardiovascular Diseases, Cancers, Degenerative Brain Diseases
Phase
Research
Status
Active
Company
About Ludger
Ludger is an established industry leader in the niche field of glycan analysis, serving the biopharmaceutical and diagnostics sectors. The company operates a dual business model, offering both high-value analytical services and a comprehensive product line of reagents, standards, and kits for glycoprofiling. Its technology is used in the quality control of FDA- and EMA-approved drugs and supports regulatory submissions. With a strong scientific foundation and ISO9001-certified operations, Ludger is positioned at the intersection of biologics development and precision medicine.
View full company profile